Replies to post #378082 on Amarin Corp Plc (AMRN)

[Jasbg]

JRoon, Remember this case were referred to here some months ago.

I'm not sure if going after OTC products in the market is the way to go for Amarin - a lot of related products out there - an endless/hopeless task:

https://www.google.com/search?q=Fish+Oil+EPA&tbm=isch&ved=2ahUKEwjpv8y77u73AhWvwQIHHZgJAeUQ2-cCegQIABAA&oq=Fish+Oil+EPA&gs_lcp=CgNpbWcQAzIECAAQEzIECAAQEzIICAAQHhAHEBMyCAgAEB4QBRATMggIABAeEAUQEzIICAAQHhAIEBMyCAgAEB4QCBATMggIABAeEAgQEzIICAAQHhAHEBMyBggAEB4QEzoECAAQQzoFCAAQgAQ6BggAEB4QBzoICAAQHhAIEAc6BggAEB4QBToGCAAQHhAIUO8MWJ0rYIw2aABwAHgAgAF4iAGoBZIBAzkuMZgBAKABAaoBC2d3cy13aXotaW1nwAEB&sclient=img&ei=ufKHYqn_Lq-Di-gPmJOEqA4&bih=699&biw=1327
------------------------------------------

I have personally (in the lack of Vazkepa yet available on the list of medicines in Denmark) - been taking a very popular refined EPA product in Europe:

https://www.amazon.de/-/en/gp/product/B007TUK2IE/ref=ox_sc_act_image_1?smid=A3M3SUVG03RQR7&psc=1 - a very well produced product it feels.
------------------------------------------

My advice to Amarin is to concentrate on stopping the - gV producers infringing 'bigtime' (clearly don't give damn) on the CDV Label that cost Amarin ½ a billion to achieve - and forget about the OTC market all together.